• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[用于哮喘和鼻炎诊断及免疫治疗的尘螨变应原安全性分析]

[Safety analysis of dust mite allergen for diagnosis and immunotherapy of asthma and rhinitis].

作者信息

Wen T, Cai Y, Chen X, Xiang L, Wang B, Zhuang Y

机构信息

Medical Acarology Laboratory, Shanghai Medical University, Shanghai 200032.

出版信息

Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1999;17(5):274-6.

PMID:12563856
Abstract

AIM

To make a retrieval investigation of safety in using Dermatophagoides farinae extract in diagnosis and immunotherapy with patients of asthma and rhinitis.

METHODS

A questionnaire evaluation of the safety use of D. farinae extract (SMU-Df) during diagnosis and immunotherapy of patients from 1974 to 1995 was carried out.

RESULTS

A total of 8,46,342 injections were statistically analysed, among whom 142 systemic adverse reactions occurred involving urticaria 0.82@10000, severe attack of asthma 0.77@10000, anaphylactic shock 0.07@10000 (CL = 1.4-12.0/million), and angioedma 0.02@10000. The time of onset of systemic reactions of immediate type was < 30 min in 32 cases-times, and 1 h and 2 h in 6 cases-times; the time to onset of late response type was 3 h-48 h in 23 cases-times with highest incidence of severe asthmatic attacks. The systemic reactions occurred in 18 subjects during skin test, in 96 cases-times during increasing dose phase, and in 14 cases-times during. Among them 6 cases were of anaphylactic shock, and none of it after emergency treatment. The major cause of manifestation of systemic reactions for 41 cases after immunotherapy with SMU-Df extract was due to over dosage errors.

CONCLUSION

The application of SMU-Df extract in skin test and immunotherapy of asthma and rhinitis sensitive to mite for the past 22 years in this country indicated that the efficacy and safety have been high.

摘要

目的

对粉尘螨提取物在哮喘和鼻炎患者诊断及免疫治疗中的使用安全性进行检索调查。

方法

对1974年至1995年期间患者在粉尘螨提取物(SMU-Df)诊断和免疫治疗期间的安全使用情况进行问卷调查评估。

结果

共对846342次注射进行了统计学分析,其中发生142例全身不良反应,包括荨麻疹0.82/10000、哮喘重度发作0.77/10000、过敏性休克0.07/10000(可信区间=1.4-12.0/百万)和血管性水肿0.02/10000。速发型全身反应的发作时间在32例次中<30分钟,在6例次中为1小时和2小时;迟发型反应的发作时间在23例次中为3小时至48小时,其中重度哮喘发作的发生率最高。全身反应发生在18名受试者的皮肤试验期间、96例次的剂量增加阶段和14例次的[此处原文缺失信息]期间。其中6例为过敏性休克,经急救后均无死亡。41例患者使用SMU-Df提取物免疫治疗后出现全身反应表现的主要原因是用药过量错误。

结论

该国过去22年中SMU-Df提取物在对螨敏感的哮喘和鼻炎皮肤试验及免疫治疗中的应用表明其疗效和安全性较高。

相似文献

1
[Safety analysis of dust mite allergen for diagnosis and immunotherapy of asthma and rhinitis].[用于哮喘和鼻炎诊断及免疫治疗的尘螨变应原安全性分析]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 1999;17(5):274-6.
2
Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.使用标准化粉尘螨提取物进行免疫治疗期间发生不良全身反应的危险因素。
Acta Otolaryngol Suppl. 1998;538:113-7.
3
[Current trends in the specific immunotherapy for allergic syndromes due to Dermatophagoides pteronyssinus].[尘螨所致过敏性综合征特异性免疫治疗的当前趋势]
Recenti Prog Med. 1994 May;85(5):285-8.
4
[Urticaria in relation to mite sensitivity and immunotherapy with Injection dermatophagoidei farinae].[与螨敏感性及粉尘螨注射液免疫疗法相关的荨麻疹]
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2008 Dec 30;26(6):422-7.
5
Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy.屋尘螨引起的变应性鼻炎:特异性舌下免疫治疗疗效评估
Allergy. 2004 May;59(5):491-7. doi: 10.1111/j.1398-9995.2004.00456.x.
6
Advances in upper airway diseases and allergen immunotherapy.上呼吸道疾病与变应原免疫治疗的进展
J Allergy Clin Immunol. 2007 Apr;119(4):872-80. doi: 10.1016/j.jaci.2006.12.613. Epub 2007 Feb 9.
7
Significant improvement in symptoms, skin test, and specific bronchial reactivity after 6 months of treatment with a depigmented, polymerized extract of Dermatophagoides pteronyssinus and D. farinae.用尘螨(屋尘螨和粉尘螨)的脱色聚合提取物治疗6个月后,症状、皮肤试验及特异性支气管反应性有显著改善。
J Investig Allergol Clin Immunol. 2003;13(4):244-51.
8
Dermatophagoides farinae mite allergen and specific immunotherapy in Shanghai.上海的粉尘螨变应原与特异性免疫治疗
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2009 Oct;27(5):419-25.
9
Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.评估在通过药物治疗和避免接触螨虫措施实现最佳控制的屋尘螨诱发过敏性哮喘儿童中舌下免疫疗法的疗效。
Pediatr Allergy Immunol. 2007 Feb;18(1):47-57. doi: 10.1111/j.1399-3038.2006.00475.x.
10
[Evaluation of the pediatric aspects of the WHO document and meta-analysis of immunotherapy].[世界卫生组织文件儿科方面的评估及免疫疗法的荟萃分析]
Allergol Immunopathol (Madr). 2000 May-Jun;28(3):82-9.